Fosfomycin Tromethamine
- Product NDC
- 63629-9470
- Requested package NDC
- 63629-9470-1
- 11-digit product format
- 636299470
- Labeler code
- 63629
- Product ID
- 63629-9470_a06194fb-7c70-4b28-b8bf-e1525a97bc10
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fosfomycin Tromethamine
- Dosage form
- GRANULE, FOR SOLUTION
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA214554
- Marketing category
- ANDA
- Marketing start
- 2021-10-22
- Marketing end
- 0000-00-00
- Substance
- FOSFOMYCIN TROMETHAMINE
- Active strength
- 3 g/1
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63629-9470 | 63629-9470-1 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214554-001 | FOSFOMYCIN TROMETHAMINE | FOSFOMYCIN TROMETHAMINE | EQ 3GM BASE/PACKET | FOR SOLUTION / ORAL | AA | 2021-10-21 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214554-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A214554-001 | FOSFOMYCIN TROMETHAMINE | EQ 3GM BASE/PACKET | FOR SOLUTION / ORAL | AA | 2021-10-21 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A214554-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fosfomycin Tromethamine | FOSFOMYCIN TROMETHAMINE | Ascend Laboratories, LLC | 48e352bc-52ea-4778-905a-60ef38a5c18a | 2025-12-17 | Warnings, Adverse reactions | 214554 ANDA214554 |
| Fosfomycin Tromethamine | FOSFOMYCIN TROMETHAMINE | Kesin Pharma Corporation | 3fa61bd4-fc55-0987-e063-6394a90abce2 | 2025-09-25 | Warnings, Adverse reactions | 214554 ANDA214554 |
| Fosfomycin Tromethamine | FOSFOMYCIN TROMETHAMINE | A-S Medication Solutions | 6b9167a9-80e9-44e1-a609-c3eb78960acf | 2023-11-01 | Warnings, Adverse reactions | 214554 ANDA214554 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-9470-1 | EA - Each | 63629-9470 | 601b4fb4-90eb-4c62-b0b6-1009e94ab281 | 1 | 2023-01-09 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63629-9470-1 | 63629947001 | 1 PACKET in 1 CARTON (63629-9470-1) > 1 GRANULE, FOR SOLUTION in 1 PACKET | 1 packet | 2022-11-28 | 0000-00-00 | No | No | Current |